Cardio Diagnostics
Get Started

Who We Serve

PatientsProvidersEmployers

Our Solutions

OverviewEpi+Gen CHD™PrecisionCHD™HeartRisk™CardioInnovate360™

Company

About UsAbout CVDCareersTechnologyResourcesNewsletterContact Us

Investors

Stock InformationSEC FilingsPress ReleasesPresentationsEmail SubscriptionCorporate GovernanceContact Investor Relations
Contact Us

Company

About UsAbout CVDCareersTechnologyResourcesNewsletterContact Us

Our Solutions

OverviewEpi+Gen CHD™PrecisionCHD™HeartRisk™CardioInnovate360™

Who We Serve

PatientsProvidersEmployers

Investors

Stock InformationSEC FilingsPress ReleasesPresentationsEmail SubscriptionCorporate GovernanceContact Investor Relations
Contact Us

2026 Cardio Diagnostics, Inc.

Privacy PolicyTerms of UseHIPAA Notice

The Cardio Diagnostics clinical laboratory is certified under the Clinical Laboratory Improvement Amendments of 1988 (CLIA) as qualified to perform high-complexity clinical laboratory testing. The Epi+Gen CHD™ and PrecisionCHD™ tests were developed, and their performance characteristics were determined by Cardio Diagnostics. These tests should be ordered by a licensed healthcare provider, and test results should be interpreted by a healthcare provider in the context of medical history, clinical signs and symptoms, and other relevant clinical information. These tests are intended for clinical purposes and have not been cleared or approved by the U.S. Food and Drug Administration (FDA).

For the Epi+Gen CHD™ test, a lower risk result does not eliminate the possibility of a coronary heart disease event occurring or that coronary heart disease is present, and a higher risk result does not imply a diagnosis of coronary heart disease or that a coronary heart disease event will occur. For the PrecisionCHD™ test, a "Signal Detected" result is not a diagnosis of coronary heart disease, and a "Signal Not Detected" result does not eliminate the possibility that coronary heart disease is present or could occur in the future. False positive and false negative test results do occur. Rx only.

In addition to a federal CLIA license, the Cardio Diagnostics clinical laboratory holds active state clinical laboratory licenses in California, Maryland, Pennsylvania, and Rhode Island. The laboratory is not currently licensed to process patient samples originating from the state of New York.

Hero Background

Subscribe to Our Newsletter

Whether you're a provider interested in what's next in precision cardiovascular medicine or a benefits leader interested in reducing costs associated with heart disease, we'll tailor resources to you.

Subscribe

Choose your edition

Providers and Policy Leaders Edition

Get curated insights for healthcare professionals interested in strengthening cardiovascular care, including primary care providers, cardiologists, healthcare administrators, and public health leaders. Here's what you'll receive by subscribing:

Insights

Clinically-reviewed perspectives on the role of AI and epigenetics in heart disease care.

Reports

Exclusive findings you can't find anywhere else, at the forefront of innovation in precision medicine.

Announcements

Key updates on what's new and next in precision cardiovascular medicine.

In the News

Webinars, events, podcasts, and publications for healthcare leaders seeking future-focused cardiovascular care solutions.

By subscribing you agree to our Privacy Policy.

Recent Insights

The Invisible Burden of Non-Obstructive Coronary Artery Disease

Report

Provider

The Invisible Burden of Non-Obstructive Coronary Artery Disease

A coronary angiogram can miss the full clinical picture of coronary heart disease. Download our whitepaper to guide your diagnostic framework.

The State of Rural Hospitals and Cardiovascular Care

Report

Provider

The State of Rural Hospitals and Cardiovascular Care

The USDA has estimated that 146 U.S. rural hospitals closed or stopped providing inpatient care between 2005 to 2023. Can a new model of care help?

Value-Based Care Technology: AI for Heart Disease Care

Article

Provider

Value-Based Care Technology: AI for Heart Disease Care

When paired with advanced technology and AI, value-based care can transform healthcare models at scale. Read more.